Skip to main content
Caplight Logo









ArcaScience

ArcaScience

Private
ParisHealthcare & Life Scienceshttps://arcascience.ai/

Last Round

Seed

Sep 3, 2025

Total Funding Raised

$9.8M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

ArcaScience is a healthtech company that provides an AI-powered platform to revolutionize benefit-risk evaluation for drug development.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Drug Discovery, Healthcare Analytics, Clinical Trials, Compliance & Risk

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

drug developmentbenefit-risk assessmentpharmacovigilanceclinical decision supportbiomedical AIpharma techregulatory submissionclinical landscape analysishealthtechR&D intelligenceevidence monitoringAI drug discoveryclinical trial designSaaS platformdrug safety

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ArcaScience Comparables

Compare ArcaScience with similar companies based on industry and business-model similarity.

ArcaScience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sable Bio
80%
DrugCard
80%
SafetySignal AI
79%

ArcaScience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 3, 2025

Key People

Founding team and executive leadership

Jean-Francois Arbona

Co-founder CTO

Founding Team

Romain Clement

Co-founder CEO

Founding Team

Romain CLEMENT

Co-founder CEO

Founding Team

ArcaScience Investors

Notable investors and investment history

ArcaScience investors
InvestorRounds
Plug and Play Tech CenterSeed, Pre Seed
Pléiade VentureSeed
BpifranceSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 3, 2026

    Grew 16% QoQ, from 25 to 29 employees.

  • Jul 26, 2026

    Monthly visitors grew 39% MoM.

Recent news

Latest coverage and updates

  • launchesSep 23, 2026

    ArcaScience Company launches Flow.

ArcaScience Filings

Explore SEC and related filing metadata, where available.

ArcaScience filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ArcaScience's valuation, stock price, and market status.

Is ArcaScience a public or private company?

ArcaScience is a private company.

What is the current stock price of ArcaScience?

ArcaScience is a private company with no public stock price. No recent secondary market data is available.

How much is ArcaScience worth (valuation)?

Valuation information for ArcaScience is not publicly available.

Can I buy ArcaScience stock?

ArcaScience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ArcaScience's last funding round?

ArcaScience's most recent funding round was Seed on September 3, 2025.

Who are the main investors in ArcaScience?

Key investors in ArcaScience include Plug and Play Tech Center, Bpifrance, Pléiade Venture.

Will ArcaScience IPO soon?

No public IPO plans have been announced for ArcaScience.

How can I track ArcaScience secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ArcaScience's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Employee Range22
Year Founded2018
Last FundingSep 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?